期刊文献+

绝经后妇女使用抗骨质疏松症药物的依从性及其影响因素分析 被引量:31

The analysis of compliance of anti-osteoporosis drug use and the influential factors in postmenopausal women
下载PDF
导出
摘要 目的探讨影响绝经后妇女使用抗骨质疏松症药物依从性的相关因素。方法收集2010年3月~2011年3月至我院骨质疏松科初诊并经过双能X线检测确诊为骨质疏松症的绝经后妇女200例。从给入组对象处方抗骨质疏松症药物起,3个月、6个月、12个月进行随访,确定患者用药情况,对自行停药的患者询问其停药原因。此外,所有入组对象在初诊时完成患者一般情况的问卷调查,每次随访时完成有关疾病和药物评价的问卷调查,对问卷调查中的各项内容与患者在随访期间是否出现自行停药进行Logistic回归分析。结果患者在不同时间段内停药率和原因不相同,1年内的累积停药率高达35.0%。与停药相关因素有教育程度、起病症状、骨质疏松家族史、服用5种以上其他药物、骨质疏松症状改善、服药是否方便、药物副作用以及药物价格。结论绝经后妇女使用抗骨质疏松症药物治疗的依从性较差,可通过增加患者对于疾病和药物的了解和认知,加强老年病人用药的管理、对不同停药原因采取相应的措施以及识别停药高危人群来提高依从性。 Objective To explore the relative factors for the therapeutic compliance of drugs for the treatment of osteoporosis in postmenopausal women.Methods Clinical data of 200 postmenopausal women diagnosed with osteoporosis by dual energy absorptiometry in the prevention and treatment center of osteoporosis from March 2010 to March 2011 were collected.All included subjects were followed up for 3,6,and 12 months after the drug being administered.The status of drug use was determined.The reasons for drug discontinuation would be asked in withdrawal patients.Additionally,all subjects were investigated using the questionnaire of general condition at first consultation.The questionnaire of the disease evaluation should be completed at each follow-up.Logistic regression was used to evaluate every item in questionnaire and drug withdrawal.Results Withdrawal rate and reasons at different time period of the treatment were different.The cumulative discontinuation rate was 35.0% in 12 months.The relative factors for drug discontinuation included education,family history of osteoporosis,symptoms,more than 5 kinds of drugs used,relief,convenience,side effect,and cost.Conclusion The therapeutic compliance of anti-osteoporosis drug use in the postmenopausal women is poor.The compliance can be improved through increasing the knowledge of osteoporosis and drugs,strengthening the management of medication in elderly patients,taking appropriate measures for different withdrawal reasons,and identifying the patients with high-risk of withdrawal.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2012年第2期139-142,138,共5页 Chinese Journal of Osteoporosis
关键词 骨质疏松症 治疗依从性 影响因素 Osteoporosis Therapeutic compliance Influential factors
  • 相关文献

参考文献15

  • 1Dawson-Hughes B,Tosteson AN,Melton LJ,et al.National Osteoporosis Foundation Guide Committee.Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.Osteoporos Int,2008,19(4):449-458.
  • 2朱汉民等.骨质疏松防治中国白皮书[J].中华健康管理学杂志,2009,:148-154.
  • 3Barrett-Connor E,Wade SW,Do TP,et al.Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications:12-month results from POSSIBLE US?Osteoporos Int,2011,Epub ahead of print.
  • 4Unson CG,Siccion E,Gaztambide J,et al.Nonadherence and osteoporosis treatment preferences of older women:a qualitative study.J Womens Health(Larchmt),2003,12:1037-1045.
  • 5Tosteson AN,Grove MR,Hammond CS,et al.Early discontinuation of treatment for osteoporosis.Am J Med,2003,115:209-216.
  • 6Rossini M,Bianchi G,Di Munno O,et al.Treatment of Osteoporosis in clinical Practice(TOP)Study Group(2006)Determinants of adherence to osteoporosis treatment in clinical practice.Osteoporos Int,2006,17:914-921.
  • 7Hadji P,Minne H,Pfeifer M,et al.Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis:a randomizedcrossover study(BALTO II).Joint Bone Spine,2008,75:303-310.
  • 8Payer J,Killinger Z,SulkováI,et al.Preferences of patients receiving bisphosphonates-how to influence the therapeutic adherence.Biomed Pharmacother,2008,62:122-124.
  • 9Kendler DL,Bessette L,Hill CD,et al.Preference and satisfaction with a6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass.Osteoporos Int,2010,21:837-846.
  • 10McHorney CA,Schousboe JT,Cline RR,et al.The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.Curr Med Res Opin,2007,23(12):3137-3152.

同被引文献281

引证文献31

二级引证文献396

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部